Lensar (LNSR) Share-based Compensation Growth (3y) (2022 - 2026)
Lensar (LNSR) Share-based Compensation Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 8.37% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | -28.31% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 13.19% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 4.11% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | -0.59% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 17.13% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 36.49% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 3.40% |
| 10 | Lensar | 101.76 Mn | 88.19 Mn | 9.78 Mn | -42.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -42.49% |
| Mar 31, 2026 | -26.33% |
| Dec 31, 2025 | -19.84% |
| Sep 30, 2025 | -20.19% |
| Jun 30, 2025 | -22.36% |
| Mar 31, 2025 | -25.89% |
| Dec 31, 2024 | -24.58% |
| Sep 30, 2024 | -24.83% |
| Jun 30, 2024 | -21.83% |
| Mar 31, 2024 | -34.50% |
| Dec 31, 2023 | 20.35% |
| Sep 30, 2023 | -32.11% |
| Jun 30, 2023 | 254.33% |
| Mar 31, 2023 | 30.14% |
| Dec 31, 2022 | 52.07% |
| Sep 30, 2022 | 124.89% |